Market Overview:
The global corticosteroids API market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, such as asthma, and the rising incidence of arthritis and other autoimmune diseases. In addition, the growing demand for corticosteroids API in Asia Pacific is contributing to the growth of this market. On the basis of type, prednisone series accounted for a major share of the global corticosteroids API market in 2017. This segment is expected to maintain its dominance during the forecast period owing to its high demand from various applications such as asthma, arthritis, and lupus erythematosus (LE). Dexamethasone series is another key type segmented in this market and it held second-largest share in 2017 on account of its high usage rates for treating various respiratory disorders such as bronchitis and pneumonia.
Product Definition:
Corticosteroids API is a naturally occurring hormone produced by the adrenal gland. It is important for the body to maintain blood pressure and regulate other functions such as inflammation, immunity, and stress response. Corticosteroids are used to treat a variety of medical conditions such as asthma, allergies, arthritis, cancer, lupus erythematosus, multiple sclerosis and skin disorders.
Prednisone Series:
The global prednisone series market is expected to witness significant growth over the forecast period. Prednisone (corticosteroid) is a type of medication that reduces inflammation by decreasing the production of cytokines in humans and animals. Corticosteroids are used for treatment of inflammatory diseases like asthma, autoimmune diseases, rheumatoid arthritis, etc.
Dexamethasone Series:
Dexamethasone series is a group of synthetic glucocorticoids with mineralocorticoid activity. Dexamethasone can be derived from two different sources, namely, cyclohexane and acetaminol. The most commonly used form of this drug is known as dexamethasone sodium phosphate. It has the same chemical structure as that of cortisol but differs in terms of its pharmacological properties and therapeutic applications.
Application Insights:
The arthritis segment dominated the global market in terms of revenue share in 2017. The high prevalence of arthritis and increasing geriatric population are the major factors contributing to its dominance over other applications. As per WHO, it is estimated that around 30-50 million people suffer from Arthritis every year, globally. Prednisone is one of the most commonly prescribed drugs for treating arthritis as well as other rheumatic diseases. It has a wide range of indications such as osteoarthritis, rheumatoid arthritis and ankylosing spondylitis among others.
The asthma segment accounted for a significant share in 2017 owing to rising awareness about early diagnosis.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players and well-established healthcare infrastructure. Moreover, rising prevalence of chronic diseases such as asthma and arthritis is expected to drive regional growth over the forecast period. Asia Pacific is expected to witness lucrative growth during the forecast period due to increasing awareness about Corticosteroids among patients, growing geriatric population prone to joint problems & other conditions associated with it, improving living standards & rapid industrialization leading towards better healthcare facilities for treatment options. In addition, government initiatives are also being undertaken in this region for spreading awareness about these drugs among patients suffering from skin disorders or respiratory allergies etc., which will further boost revenue generation capacity over next eight years.
Growth Factors:
- Increasing incidence of respiratory diseases: The global incidence of respiratory diseases is increasing due to the changing lifestyle and environmental conditions. This is expected to drive the demand for corticosteroids API in the coming years.
- Growing awareness about asthma and other respiratory disorders: There is a growing awareness among people about asthma and other respiratory disorders. This is likely to increase the demand for corticosteroids API in the near future.
- Rising prevalence of allergies: The prevalence of allergies is increasing at an alarming rate across the globe, which is expected to boost the demand for corticosteroids API in upcoming years.
- Technological advancements in inhalers: Inhalers are becoming more sophisticated with each passing day with technological advancements such as dry powder inhalers (DPIs). This will fuel growth prospects for corticosteroid APIs over next few years . 5) Expanding product portfolios by key players: Key players are expanding their product portfolios by launching new products and variants catering to different segments of patients suffering from respiratory diseases
Scope Of The Report
Report Attributes
Report Details
Report Title
Corticosteroids API Market Research Report
By Type
Prednisone Series, Dexamethasone Series, Betamethasone Series, Triamcinolone, Methylprednisolone, Spironolactone, Other
By Application
Asthma, Arthritis, Iupus, Allergies, Other
By Companies
Pfizer Inc, Sanofi Active Ingredient Solutions, TEVA, Hovione, Farmabios, Steroid SpA, Avik Pharmaceutical, Anuh Pharma, Symbiotec, Wellona Pharma, Tianjin Tianyao Pharmaceutical, Zhejiang Xianju Pharmaceutical, Henan Lihua Pharmaceutical, Shanghai New Hualian Pharmaceutical, Zhejiang Hengdian Apeloa, Shandong Sito Bio-tech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
222
Number of Tables & Figures
156
Customization Available
Yes, the report can be customized as per your need.
Global Corticosteroids API Market Report Segments:
The global Corticosteroids API market is segmented on the basis of:
Types
Prednisone Series, Dexamethasone Series, Betamethasone Series, Triamcinolone, Methylprednisolone, Spironolactone, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Asthma, Arthritis, Iupus, Allergies, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer Inc
- Sanofi Active Ingredient Solutions
- TEVA
- Hovione
- Farmabios
- Steroid SpA
- Avik Pharmaceutical
- Anuh Pharma
- Symbiotec
- Wellona Pharma
- Tianjin Tianyao Pharmaceutical
- Zhejiang Xianju Pharmaceutical
- Henan Lihua Pharmaceutical
- Shanghai New Hualian Pharmaceutical
- Zhejiang Hengdian Apeloa
- Shandong Sito Bio-tech
Highlights of The Corticosteroids API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prednisone Series
- Dexamethasone Series
- Betamethasone Series
- Triamcinolone
- Methylprednisolone
- Spironolactone
- Other
- By Application:
- Asthma
- Arthritis
- Iupus
- Allergies
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Corticosteroids API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Corticosteroids API is a prescription medication used to reduce inflammation.
Some of the major companies in the corticosteroids api market are Pfizer Inc, Sanofi Active Ingredient Solutions, TEVA, Hovione, Farmabios, Steroid SpA, Avik Pharmaceutical, Anuh Pharma, Symbiotec, Wellona Pharma, Tianjin Tianyao Pharmaceutical, Zhejiang Xianju Pharmaceutical, Henan Lihua Pharmaceutical, Shanghai New Hualian Pharmaceutical, Zhejiang Hengdian Apeloa, Shandong Sito Bio-tech.
The corticosteroids api market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Corticosteroids API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Corticosteroids API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Corticosteroids API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Corticosteroids API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Corticosteroids API Market Size & Forecast, 2018-2028
4.5.1 Corticosteroids API Market Size and Y-o-Y Growth
4.5.2 Corticosteroids API Market Absolute $ Opportunity
Chapter 5 Global Corticosteroids API Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Corticosteroids API Market Size Forecast by Type
5.2.1 Prednisone Series
5.2.2 Dexamethasone Series
5.2.3 Betamethasone Series
5.2.4 Triamcinolone
5.2.5 Methylprednisolone
5.2.6 Spironolactone
5.2.7 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Corticosteroids API Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Corticosteroids API Market Size Forecast by Applications
6.2.1 Asthma
6.2.2 Arthritis
6.2.3 Iupus
6.2.4 Allergies
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Corticosteroids API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Corticosteroids API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Corticosteroids API Analysis and Forecast
9.1 Introduction
9.2 North America Corticosteroids API Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Corticosteroids API Market Size Forecast by Type
9.6.1 Prednisone Series
9.6.2 Dexamethasone Series
9.6.3 Betamethasone Series
9.6.4 Triamcinolone
9.6.5 Methylprednisolone
9.6.6 Spironolactone
9.6.7 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Corticosteroids API Market Size Forecast by Applications
9.10.1 Asthma
9.10.2 Arthritis
9.10.3 Iupus
9.10.4 Allergies
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Corticosteroids API Analysis and Forecast
10.1 Introduction
10.2 Europe Corticosteroids API Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Corticosteroids API Market Size Forecast by Type
10.6.1 Prednisone Series
10.6.2 Dexamethasone Series
10.6.3 Betamethasone Series
10.6.4 Triamcinolone
10.6.5 Methylprednisolone
10.6.6 Spironolactone
10.6.7 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Corticosteroids API Market Size Forecast by Applications
10.10.1 Asthma
10.10.2 Arthritis
10.10.3 Iupus
10.10.4 Allergies
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Corticosteroids API Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Corticosteroids API Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Corticosteroids API Market Size Forecast by Type
11.6.1 Prednisone Series
11.6.2 Dexamethasone Series
11.6.3 Betamethasone Series
11.6.4 Triamcinolone
11.6.5 Methylprednisolone
11.6.6 Spironolactone
11.6.7 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Corticosteroids API Market Size Forecast by Applications
11.10.1 Asthma
11.10.2 Arthritis
11.10.3 Iupus
11.10.4 Allergies
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Corticosteroids API Analysis and Forecast
12.1 Introduction
12.2 Latin America Corticosteroids API Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Corticosteroids API Market Size Forecast by Type
12.6.1 Prednisone Series
12.6.2 Dexamethasone Series
12.6.3 Betamethasone Series
12.6.4 Triamcinolone
12.6.5 Methylprednisolone
12.6.6 Spironolactone
12.6.7 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Corticosteroids API Market Size Forecast by Applications
12.10.1 Asthma
12.10.2 Arthritis
12.10.3 Iupus
12.10.4 Allergies
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Corticosteroids API Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Corticosteroids API Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Corticosteroids API Market Size Forecast by Type
13.6.1 Prednisone Series
13.6.2 Dexamethasone Series
13.6.3 Betamethasone Series
13.6.4 Triamcinolone
13.6.5 Methylprednisolone
13.6.6 Spironolactone
13.6.7 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Corticosteroids API Market Size Forecast by Applications
13.10.1 Asthma
13.10.2 Arthritis
13.10.3 Iupus
13.10.4 Allergies
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Corticosteroids API Market: Competitive Dashboard
14.2 Global Corticosteroids API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer Inc
14.3.2 Sanofi Active Ingredient Solutions
14.3.3 TEVA
14.3.4 Hovione
14.3.5 Farmabios
14.3.6 Steroid SpA
14.3.7 Avik Pharmaceutical
14.3.8 Anuh Pharma
14.3.9 Symbiotec
14.3.10 Wellona Pharma
14.3.11 Tianjin Tianyao Pharmaceutical
14.3.12 Zhejiang Xianju Pharmaceutical
14.3.13 Henan Lihua Pharmaceutical
14.3.14 Shanghai New Hualian Pharmaceutical
14.3.15 Zhejiang Hengdian Apeloa
14.3.16 Shandong Sito Bio-tech
